{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T09:15:54Z","timestamp":1776417354403,"version":"3.51.2"},"reference-count":42,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004586","name":"Carlos Chagas Filho Foundation for Research Support of Rio de Janeiro State","doi-asserted-by":"publisher","award":["E-26\/201.591\/2021"],"award-info":[{"award-number":["E-26\/201.591\/2021"]}],"id":[{"id":"10.13039\/501100004586","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - General Subjects"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.bbagen.2026.130930","type":"journal-article","created":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T16:31:43Z","timestamp":1773073903000},"page":"130930","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Iodinated contrast agents decrease the activity of multidrug resistance protein, cell migration, and induce cell death in different tumor cell lines and glioblastoma spheroids"],"prefix":"10.1016","volume":"1870","author":[{"given":"Jessica Sodr\u00e9 Silva","family":"de Abreu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morgana Teixeira Lima","family":"Castelo-Branco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janaina","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbagen.2026.130930_bb0005","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1007\/978-1-4612-1190-7_63","article-title":"Radiocontrast: History and evolution","volume":"63","author":"Quader","year":"2000","journal-title":"Angiol. Textbook"},{"key":"10.1016\/j.bbagen.2026.130930_bb0010","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.mric.2017.06.003","article-title":"Current radiographic iodinated contrast","volume":"4","author":"Spampinato","year":"2017","journal-title":"Magn. Reson. Imaging Clin. N. Am."},{"key":"10.1016\/j.bbagen.2026.130930_bb0015","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/s41598-017-00709-4","article-title":"Sorafenib and 2,3,5-triiodobenzoic acid-loaded imageable microspheres for transarterial embolization of a liver tumor","volume":"1","author":"Choi","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbagen.2026.130930_bb0020","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1016\/j.jacc.2016.05.099","article-title":"Contrast-induced acute kidney injury","volume":"13","author":"McCullough","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.bbagen.2026.130930_bb0025","doi-asserted-by":"crossref","first-page":"86832","DOI":"10.1155\/2013\/868321","article-title":"Role of reactive oxygen species in the pathogenesis of radiocontrast-induced nephropathy","volume":"2013","author":"Pisani","year":"2013","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.bbagen.2026.130930_bb0030","first-page":"119","article-title":"Iodinated contrasts and their potential for antitumor chemotherapy","volume":"22","author":"Abreu","year":"2022","journal-title":"Curr. Top. Biochem. Res."},{"issue":"1","key":"10.1016\/j.bbagen.2026.130930_bb0035","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1097\/00004424-198001000-00011","article-title":"Toxicity of X-ray contrast media in cell cultures","author":"Kormano","year":"1980","journal-title":"Invest. Radiol."},{"key":"10.1016\/j.bbagen.2026.130930_bb0040","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1097\/00004424-198603000-00008","article-title":"Effects of radiographic contrast media on monolayer cell cultures","volume":"3","author":"Nordby","year":"1986","journal-title":"Invest. Radiol."},{"issue":"2","key":"10.1016\/j.bbagen.2026.130930_bb0045","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s12013-019-00868-3","article-title":"The effects of iodinated radiographic contrast media on multidrug-resistant K562\/dox cells: mitochondria impairment and P-glycoprotein inhibition","volume":"77","author":"Supawat","year":"2019","journal-title":"Cell Biochem. Biophys."},{"issue":"5","key":"10.1016\/j.bbagen.2026.130930_bb0050","first-page":"1879","article-title":"Effect of inhibitors of plant cell division on mammalian tumor cells in vitro","volume":"41","author":"Zilkah","year":"1981","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.bbagen.2026.130930_bb0055","doi-asserted-by":"crossref","first-page":"385","DOI":"10.2174\/157340609788681485","article-title":"Cell nucleus directed 2,3,5-triiodobenzoic acid conjugates","volume":"5","author":"Sturzu","year":"2009","journal-title":"Med. Chem."},{"key":"10.1016\/j.bbagen.2026.130930_bb0060","first-page":"143","article-title":"2,3,5-triiodobenzoic acid, a contrast agent, induces intrinsic caspase-dependent cell death in NSCLC","volume":"22","author":"Ferr\u00e3o","year":"2018","journal-title":"Curr. Top. Pharmacol."},{"issue":"6","key":"10.1016\/j.bbagen.2026.130930_bb0065","doi-asserted-by":"crossref","first-page":"5199","DOI":"10.1007\/s11033-021-06524-5","article-title":"The contrast agent 2,3,5-triiodobenzoic acid (TIBA) induces cell death in tumor cells through the generation of reactive oxygen species","volume":"48","author":"de Abreu","year":"2021","journal-title":"Mol. Biol. Rep."},{"issue":"9","key":"10.1016\/j.bbagen.2026.130930_bb0070","doi-asserted-by":"crossref","first-page":"3233","DOI":"10.3390\/ijms21093233","article-title":"Mechanisms of multidrug resistance in Cancer chemotherapy","volume":"21","author":"Bukowski","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbagen.2026.130930_bb0075","doi-asserted-by":"crossref","first-page":"218","DOI":"10.3389\/fnins.2015.00218","article-title":"Inhibition of multidrug resistance protein 1 (MRP1) improves chemotherapy drug response in primary and recurrent glioblastoma multiforme","volume":"9","author":"Tivnan","year":"2015","journal-title":"Front. Neurosci."},{"issue":"1","key":"10.1016\/j.bbagen.2026.130930_bb0080","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3390\/molecules23010119","article-title":"Towards comprehension of the ABCB1\/P-glycoprotein role in chronic myeloid Leukemia","volume":"23","author":"Maia","year":"2018","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.bbagen.2026.130930_bb0085","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","article-title":"Hallmarks of Cancer: new dimensions","volume":"12","author":"Hanahan","year":"2022","journal-title":"Cancer Discov."},{"issue":"1","key":"10.1016\/j.bbagen.2026.130930_bb0090","doi-asserted-by":"crossref","DOI":"10.21769\/BioProtoc.3128","article-title":"Analysis of the mitochondrial membrane potential using the cationic JC-1 dye as a sensitive fluorescent probe","volume":"9","author":"Sivandzade","year":"2019","journal-title":"Bio-Protoc."},{"issue":"1","key":"10.1016\/j.bbagen.2026.130930_bb0095","article-title":"Tumor microenvironment in glioblastoma: current and emerging concepts","volume":"5","author":"Sharma","year":"2023","journal-title":"Neurooncol. Adv."},{"key":"10.1016\/j.bbagen.2026.130930_bb0105","doi-asserted-by":"crossref","DOI":"10.1002\/ijc.33588","article-title":"Cancer statistics for the year 2020: an overview","author":"Ferlay","year":"2021","journal-title":"Int. J. Cancer"},{"issue":"4","key":"10.1016\/j.bbagen.2026.130930_bb0110","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1021\/jm801389m","article-title":"Topological polar surface area defines substrate transport by multidrug resistance associated protein 1 (MRP1\/ABCC1)","volume":"52","author":"Fernandes","year":"2009","journal-title":"J. Med. Chem."},{"issue":"12","key":"10.1016\/j.bbagen.2026.130930_bb0125","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1016\/j.bbamcr.2016.09.012","article-title":"Activation of apoptosis signalling pathways by reactive oxygen species","volume":"1863","author":"Redza-Dutordoir","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"issue":"1","key":"10.1016\/j.bbagen.2026.130930_bb0130","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1186\/s13046-018-0909-x","article-title":"The role of cellular reactive oxygen species in cancer chemotherapy","volume":"37","author":"Yang","year":"2018","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.bbagen.2026.130930_bb0135","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/s12276-020-0384-2","article-title":"ROS in cancer therapy: the bright side of the moon","volume":"52","author":"Perillo","year":"2020","journal-title":"Exp. Mol. Med."},{"issue":"11","key":"10.1016\/j.bbagen.2026.130930_bb0140","doi-asserted-by":"crossref","first-page":"3166","DOI":"10.1002\/cam4.881","article-title":"Erlotinib induces the human non-small-cell lung cancer cells apoptosis via activating ROS-dependent JNK pathways","volume":"5","author":"Shan","year":"2016","journal-title":"Cancer Med."},{"issue":"1","key":"10.1016\/j.bbagen.2026.130930_bb0115","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s12943-018-0780-6","article-title":"Chronic myeloid leukemia: the paradigm of targeting oncogenic tyrosine kinase signaling and counteracting resistance for successful cancer therapy","volume":"17","author":"Soverini","year":"2018","journal-title":"Mol. Cancer"},{"issue":"2","key":"10.1016\/j.bbagen.2026.130930_bb0145","doi-asserted-by":"crossref","first-page":"753","DOI":"10.3892\/ijo.2016.3558","article-title":"Influence of doxorubicin on apoptosis and oxidative stress in breast cancer cell lines","volume":"49","author":"Pilco-Ferreto","year":"2016","journal-title":"Int. J. Oncol."},{"issue":"11","key":"10.1016\/j.bbagen.2026.130930_bb0150","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0081162","article-title":"Cisplatin induces a mitochondrial-ROS response that contributes to cytotoxicity depending on mitochondrial redox status and bioenergetic functions","volume":"8","author":"Marullo","year":"2013","journal-title":"PloS One"},{"issue":"4","key":"10.1016\/j.bbagen.2026.130930_bb0155","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/s41419-021-03614-x","article-title":"Regulated cell death pathways in doxorubicin-induced cardiotoxicity","volume":"12","author":"Christidi","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbagen.2026.130930_bb0160","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.750507","article-title":"Mechanisms of chemotherapy-induced neurotoxicity","volume":"13","author":"Was","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bbagen.2026.130930_bb0165","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/bs.acr.2022.03.005","article-title":"Nephrotoxicity in cancer treatment: an update","volume":"155","author":"Chen","year":"2022","journal-title":"Adv. Cancer Res."},{"issue":"11","key":"10.1016\/j.bbagen.2026.130930_bb0170","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1016\/j.bcp.2005.03.001","article-title":"Reversal of in vitro cellular MRP1 and MRP2 mediated vincristine resistance by the flavonoid myricetin","volume":"69","author":"van Zanden","year":"2005","journal-title":"Biochem. Pharmacol."},{"issue":"1","key":"10.1016\/j.bbagen.2026.130930_bb0175","first-page":"17","article-title":"Mechanisms of temozolomide resistance in glioblastoma - a comprehensive review","volume":"4","author":"Singh","year":"2021","journal-title":"Cancer Drug Resist."},{"issue":"4","key":"10.1016\/j.bbagen.2026.130930_bb0180","doi-asserted-by":"crossref","first-page":"761","DOI":"10.3390\/cancers13040761","article-title":"Tumor heterogeneity in glioblastomas: from light microscopy to molecular pathology","volume":"13","author":"Becker","year":"2021","journal-title":"Cancers (Basel)."},{"issue":"1","key":"10.1016\/j.bbagen.2026.130930_bb0185","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/bit.26845","article-title":"3D tumor spheroids as in vitro models to mimic in vivo human solid tumors resistance to therapeutic drugs","volume":"116","author":"Nunes","year":"2019","journal-title":"Biotechnol. Bioeng."},{"issue":"3","key":"10.1016\/j.bbagen.2026.130930_bb0190","first-page":"481","article-title":"Glioblastoma glycolytic signature predicts unfavorable prognosis, immunological heterogeneity, and ENO1 promotes microglia M2 polarization and cancer cell malignancy","volume":"30","author":"Liang","year":"2023","journal-title":"Cancer Gene Ther."},{"issue":"8","key":"10.1016\/j.bbagen.2026.130930_bb0195","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1021\/acschembio.8b00251","article-title":"Identification of compounds that decrease glioblastoma growth and glucose uptake in vitro","volume":"13","author":"Landis","year":"2018","journal-title":"ACS Chem. Biol."},{"issue":"1","key":"10.1016\/j.bbagen.2026.130930_bb0200","doi-asserted-by":"crossref","first-page":"154","DOI":"10.3390\/cancers12010154","article-title":"Targeting glucose transporters for breast Cancer therapy: the effect of natural and synthetic compounds","volume":"12","author":"Barbosa","year":"2020","journal-title":"Cancers (Basel)."},{"issue":"1","key":"10.1016\/j.bbagen.2026.130930_bb0205","doi-asserted-by":"crossref","first-page":"3526","DOI":"10.1038\/s41467-021-23752-2","article-title":"Targeted PI3K\/AKT-hyperactivation induces cell death in chronic lymphocytic leukemia","volume":"12","author":"Ecker","year":"2021","journal-title":"Nat. Commun."},{"issue":"7","key":"10.1016\/j.bbagen.2026.130930_bb0210","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.3390\/cancers15072116","article-title":"Mechanisms of resistance and current treatment options for glioblastoma multiforme (GBM)","volume":"15","author":"Yalamarty","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"8","key":"10.1016\/j.bbagen.2026.130930_bb0215","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.3174\/ajnr.A4755","article-title":"MRI appearance of intracerebral iodinated contrast agents: is it possible to distinguish extravasated contrast agent from Hemorrhage?","volume":"37","author":"Nikoubashman","year":"2016","journal-title":"AJNR Am. J. Neuroradiol."},{"issue":"21","key":"10.1016\/j.bbagen.2026.130930_bb0220","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1091\/mbc.E18-02-0123","article-title":"Mechanisms of invasion and motility of high-grade gliomas in the brain","volume":"29","author":"Mair","year":"2018","journal-title":"Mol. Biol. Cell"}],"container-title":["Biochimica et Biophysica Acta (BBA) - General Subjects"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304416526000309?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304416526000309?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T08:21:07Z","timestamp":1776414067000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304416526000309"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":42,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S0304416526000309"],"URL":"https:\/\/doi.org\/10.1016\/j.bbagen.2026.130930","relation":{},"ISSN":["0304-4165"],"issn-type":[{"value":"0304-4165","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Iodinated contrast agents decrease the activity of multidrug resistance protein, cell migration, and induce cell death in different tumor cell lines and glioblastoma spheroids","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - General Subjects","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbagen.2026.130930","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"130930"}}